Novel treatment options for acute myelocytic leukemia

Author： Mathisen Michael S   Kantarjian Hagop M   Cortes Jorge   Ravandi Farhad   Jabbour Elias J  

Publisher： Future Science

ISSN： 2041-6792

Source： Clinical Investigation, Vol.3, Iss.10, 2013-10, pp. : 979-990

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PML/RARα(+) Hypergranular Acute Promyelocytic Leukemia (M3) Developing into an M3 Acute Myelocytic Leukemia without PML/RARα

By  

Acta Haematologica, Vol. 104, Iss. 2-3, 2001-01 ,pp. : 124-127

Karger

Access to resources Recommend Favorite

Treatment of Relapsed Acute Promyelocytic Leukemia

By  

Oncology Research and Treatment, Vol. 26, Iss. 4, 2003-09 ,pp. : 373-379

Karger

Access to resources Recommend Favorite

Novel treatment options for ulcerative colitis

By Vaughn Byron P   Moss Alan C  

Clinical Investigation, Vol. 3, Iss. 11, 2013-11 ,pp. : 1057-1069

Future Science

Access to resources Recommend Favorite

Recent progress in the treatment of infant acute lymphoblastic leukemia

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 5, 2015-10 ,pp. : 811-819

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute Myeloid Leukemia Unlikely Related to Trabectedin Treatment

By  

Acta Haematologica, Vol. 126, Iss. 4, 2011-09 ,pp. : 238-239

Karger

Access to resources Recommend Favorite